These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30057216)

  • 21. Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy.
    Kim JY; Chung EJ; Kim JH; Jung KY; Lee WY
    Mov Disord; 2006 Dec; 21(12):2263-4. PubMed ID: 17013903
    [No Abstract]   [Full Text] [Related]  

  • 22. Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies.
    Planche V; Marques A; Ulla M; Ruivard M; Durif F
    Cerebellum; 2014 Jun; 13(3):318-22. PubMed ID: 24218114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-glutamic acid decarboxylase (GAD) positive cerebellar Ataxia with transitioning to progressive encephalomyelitis with rigidity and myoclonus (PERM), responsive to immunotherapy: A case report and review of literature.
    Jazebi N; Rodrigo S; Gogia B; Shawagfeh A
    J Neuroimmunol; 2019 Jul; 332():135-137. PubMed ID: 31015081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase.
    Ishida K; Mitoma H; Song SY; Uchihara T; Inaba A; Eguchi S; Kobayashi T; Mizusawa H
    Ann Neurol; 1999 Aug; 46(2):263-7. PubMed ID: 10443895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presynaptic inhibition of cerebellar GABAergic transmission by glutamate decarboxylase autoantibodies in progressive cerebellar ataxia.
    Takenoshita H; Shizuka-Ikeda M; Mitoma H; Song S; Harigaya Y; Igeta Y; Yaguchi M; Ishida K; Shoji M; Tanaka M; Mizusawa H; Okamoto K
    J Neurol Neurosurg Psychiatry; 2001 Mar; 70(3):386-9. PubMed ID: 11181864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies.
    Hosoi Y; Suzuki-Sakao M; Terada T; Konishi T; Ouchi Y; Miyajima H; Kono S
    J Neurol; 2013 Dec; 260(12):3086-92. PubMed ID: 24091766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.
    Markakis I; Alexiou E; Xifaras M; Gekas G; Rombos A
    Clin Neurol Neurosurg; 2008 Jun; 110(6):619-21. PubMed ID: 18433986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palatal myoclonus, abnormal eye movements, and olivary hypertrophy in GAD65-related disorder.
    Macaron G; Willis MA; Ontaneda D; Fernandez H; Kim S; Jones SE; Pioro EP; Cohen JA
    Neurology; 2020 Feb; 94(6):273-275. PubMed ID: 31892635
    [No Abstract]   [Full Text] [Related]  

  • 29. Vertical nystagmus associated with glutamic acid decarboxylase antibodies responding to cyclophosphamide.
    Baizabal-Carvallo JF; Alonso-Juarez M
    J Neuroimmunol; 2018 Apr; 317():5-7. PubMed ID: 29501085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmunity as a prognostic factor in sporadic adult onset cerebellar ataxia.
    Sivera R; Martín N; Boscá I; Sevilla T; Muelas N; Azorín I; Vílchez JJ; Bolonio M; Donat E; Ribes-Koninckx C; Bataller L
    J Neurol; 2012 May; 259(5):851-4. PubMed ID: 21984193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis.
    Georgieva Z; Parton M
    BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24419643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebellar ataxia associated with anti-glutamic acid decarboxylase (anti-GAD) autoantibodies: a rare and puzzling disease.
    Teive HA
    Arq Neuropsiquiatr; 2017 Mar; 75(3):137-138. PubMed ID: 28355318
    [No Abstract]   [Full Text] [Related]  

  • 33. A patient with type 1 diabetes mellitus and cerebellar ataxia associated with high titer of circulating anti-glutamic acid decarboxylase antibodies.
    Iwasaki H; Sato R; Shichiri M; Hirata Y
    Endocr J; 2001 Apr; 48(2):261-8. PubMed ID: 11456277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
    Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
    JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutamic acid decarboxylase autoantibodies and neurological disorders.
    Vianello M; Tavolato B; Giometto B
    Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies.
    Ishida K; Mitoma H; Mizusawa H
    J Neurol Sci; 2008 Aug; 271(1-2):186-90. PubMed ID: 18534624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity.
    Costa M; Saiz A; Casamitjana R; Castañer MF; Sanmartí A; Graus F; Jaraquemada D
    Clin Exp Immunol; 2002 Sep; 129(3):471-8. PubMed ID: 12197888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies.
    Muñiz-Castrillo S; Vogrig A; Joubert B; Pinto AL; Gonçalves D; Chaumont H; Rogemond V; Picard G; Fabien N; Honnorat J
    Cerebellum; 2020 Oct; 19(5):715-721. PubMed ID: 32592031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapidly progressing cerebellar ataxia associated with anti-GAD antibodies.
    Quintas S; Ruiz RL; Zapata-Wainberg G; Vivancos J
    Neurologia (Engl Ed); 2018 May; 33(4):273-275. PubMed ID: 27091680
    [No Abstract]   [Full Text] [Related]  

  • 40. Autoantibodies to glutamic acid decarboxylase in palatal myoclonus and epilepsy.
    Nemni R; Braghi S; Natali-Sora MG; Lampasona V; Bonifacio E; Comi G; Canal N
    Ann Neurol; 1994 Oct; 36(4):665-7. PubMed ID: 7944301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.